Most Read Articles
Pearl Toh, 6 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.

Combined pre- and postcapillary PH associated with worst survival in chronic kidney disease

21 Dec 2019

Chronic kidney disease (CKD) patients referred for right heart catheterization commonly have pulmonary hypertension (PH), with the combination of pre- and postcapillary PH subtypes associated with worst survival, a study reports.

Researchers looked at 12,618 patients with a right heart catheterization. Of these, 73.4 percent of patients with CKD and 56.9 percent of those without CKD presented with PH. The most common PH subtypes were isolated postcapillary PH (39.0 percent) and combined pre- and postcapillary PH (38.3 percent) in the CKD cohort, and precapillary PH (35.9 percent) in the non-CKD cohort.

The associations of mortality with mean pulmonary artery pressure, pulmonary capillary wedge pressure and right atrial pressure were similar in both the CKD and non-CKD cohorts.

On multivariable Cox proportional hazards analysis, precapillary PH conferred the highest mortality risk among patients in the non-CKD cohort (hazard ratio [HR], 2.27, 95 percent confidence interval [CI], 2.00–2.57).

In contrast, combined pre- and postcapillary PH was associated with the highest mortality risk in the CKD cohort. The HRs for mortality according to glomerular filtration rate categories were as follows: 1.89 (95 percent CI, 1.57–2.28) in G3a, 1.87 (95 percent CI, 1.52–2.31) in G3b, 2.13 (95 percent CI, 1.52–2.97) in G4 and 1.63 (95 percent CI, 1.12–2.36) in G5/G5D.

The study had several limitations, such as those inherent in its observational nature. Serum creatinine data in the 6 months preceding catheterization might not reflect true baseline CKD. Finally, the findings might not be generalizable to the general CKD population as the cohort included only those referred for right heart catheterization.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 6 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.